Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Donald Trump charged with 37 counts in classified documents case
    • Erdoğan taps former Goldman Sachs banker to head Turkey’s central bank
    • Ukraine sends western tanks into battle as counter-offensive gets under way
    • Donald Trump says he has been indicted on federal charges in documents probe
    • Canadian wildfire smoke jars New York with ‘movie of the future’
  • UK
    Sections
    • UK Home
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • Johnson quits parliament in protest at MPs’ ‘kangaroo court’
    • How stubborn inflation has undermined the UK housing market
    • Boris Johnson calls time on parliament ‘for now’ — and that spells trouble for Sunak
    • Apache announces end to North Sea drilling hours after UK scales back windfall tax
    • Crypto ownership doubles in UK before new rules kick in
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Goldman, Exane and Schroders cut ties with Odey Asset Management after assault claims
    • Financier who used fraud proceeds to fund ‘lavish lifestyle’ sentenced to 14 years
    • How the Barclays lost The Telegraph
    • Anne Boden stepped down as Starling CEO after investor clash
    • FCA investigates Odey Asset Management
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Live news updates from June 9: Trump charged with 37 counts, Boris Johnson to stand down from parliament
    • Goldman, Exane and Schroders cut ties with Odey Asset Management after assault claims
    • Binance US to suspend dollar transactions after payment partners pause activity
    • Norway seeks to open vast ocean area to deep-sea mining
    • FCA investigates Odey Asset Management
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Apple’s Vision Pro headset has made the metaverse feel outdated
    • Trump indictment brings him closer to the danger zone
    • How US cities became one big parking lot
    • Luxury goods: Europe’s joke on the world
    • Ukraine’s dam explosion is a red line: Russia must feel the consequences
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Too good to be true? The fake recruiters targeting jobseekers
    • Can a virtual PA turbocharge your career?
    • Anti-monarchist Graham Smith: The British royals are ‘tax-funded Kardashians’
    • FT business books: what to read this month
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • François Hollande: ‘Putin cannot be seduced. He respects force’
    • How Crispin Odey evaded sexual assault allegations for decades
    • Don’t blame us for AI’s threat to humanity, we’re just the technologists
    • An Albanian adventure
    • Buying into Comporta, bohemian enclave turned luxury hotspot
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Medical science

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 9 June, 2023
    Biotech
    UK cell therapy start-up agrees AstraZeneca partnership worth up to $2bn

    Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases

  • Saturday, 3 June, 2023
    ObituaryHarald zur Hausen
    Harald zur Hausen, virologist, 1936-2023

    Nobel Prize winner who discovered the cause of cervical cancer in humans

  • Friday, 2 June, 2023
    Cannabis industry
    UK medical cannabis group woos patients to buy into the business

    Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production

  • Friday, 2 June, 2023
    Health sector
    More than 400 Grail patients incorrectly told they may have cancer

    Error prompts life assurance customers to pause or review relationship with early detection biotech

  • Friday, 2 June, 2023
    David Strain
    Vaping as a cure for smoking has brought its own ills

    Marketing attractive nicotine products to children risks a whole generation’s health

  • Thursday, 1 June, 2023
    Genomics
    ‘Primate AI algorithm’ predicts genetic health risks

    Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans

  • Thursday, 1 June, 2023
    Mariana Mazzucato
    Preparing for the next pandemic will take a global commitment

    The leaked draft of the WHO Pandemic Accord contains worrying signs

  • Thursday, 1 June, 2023
    Helen Thomas
    Ailing UK life sciences sector will need further treatment

    Policy prescriptions are plentiful but momentum and money behind them is lacking

  • Tuesday, 30 May, 2023
    Coronavirus
    China investigated Covid lab leak claims, says top scientist

    Health official’s admission undermines Beijing’s dismissals that virus could have emerged from Wuhan facility

  • Wednesday, 24 May, 2023
    Biotech
    UK to announce funding boost for life sciences

    Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing

  • Wednesday, 24 May, 2023
    The FT ViewThe editorial board
    Investors can play their part in the war on superbugs

    As McDonald’s is targeted, governments also need to tighten and enforce rules

  • Wednesday, 24 May, 2023
    AI-based ‘digital bridge’ enables paraplegic patient to walk

    Neurotechnology restores natural gait with device that decodes brain’s signals for people with spinal injuries

  • Tuesday, 23 May, 2023
    Anjana Ahuja
    New surgical procedure makes us question what it means to be alive

    The organ recovery technique has provoked criticism from within the scientific community

  • Wednesday, 17 May, 2023
    The Big Read
    Quick blood tests to spot cancer: will they help or harm patients?

    Investors are pouring billions into companies claiming they can analyse DNA to find the disease early. But some scientists question if they really work

  • Sunday, 14 May, 2023
    Dementia
    Japan pushes for strong pledges on tackling dementia from G7 allies

    Alzheimer’s advocates call for ambitious declaration to match the scope of commitments made 10 years ago

  • Friday, 12 May, 2023
    UK politics & policy
    ‘Cultural sniffiness’ over profit is hurting NHS drug trials, Labour warns

    Shadow health secretary sets out plan to boost clinical research

  • Friday, 12 May, 2023
    Simon Schama
    The thwarting of science will always be a human failing

    From India to Britain, we have always managed to get in the way of our own inventiveness

  • Thursday, 11 May, 2023
    Mpox
    Mpox is no longer a global health emergency, says WHO

    Viral disease previously known as monkeypox has caused more than 87,000 infections and 140 deaths

  • Thursday, 11 May, 2023
    Science
    Study reveals scale of ‘science scam’ in academic publishing

    One in 5 biomedical articles may contain faked data, with Chinese paper mills leading way

  • Wednesday, 10 May, 2023
    Genomics
    Expanded ‘pan-genome’ database aims to improve treatment of diseases

    Project discovers more variation in DNA than expected, offering insights into human diversity

  • Monday, 8 May, 2023
    Dementia
    Two Alzheimer’s drugs offer hope to patients after decades of waiting

    In clinical trials, the medications slowed the progress of the degenerative disease that affects 50mn worldwide

  • Friday, 5 May, 2023
    Coronavirus
    WHO says Covid-19 emergency is over

    UN health body declares end to acute phase of pandemic after at least 20mn deaths

  • Friday, 5 May, 2023
    Wellcome Trust
    Wellcome Trust to triple size of Cambridge genome campus

    Biggest biomedical charity makes first investment in science infrastructure from its endowment

  • Friday, 28 April, 2023
    Special Report
    The Americas’ Fastest Growing Companies

    The FT’s fourth annual ranking of the region’s businesses by revenue growth. Plus: companies with the ‘last-mover advantage’; cannabis corporations on the rise; is Moderna a one trick pony?

  • Wednesday, 26 April, 2023
    US regulators approve first human pill derived from faecal matter

    FDA gives green light to C. difficile treatment in boost for microbiome drug developers

Previous page You are on page 1 Next page

Be part of FT Community

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
Clinical Data Management in Healthcare & Life Sciences Research
Innovating and adapting as technology evolves
Tuesday, 27th JuneOnline
FT Live
US Pharma and Biotech Summit
Exploring trends and innovations in life sciences across the United States
Tuesday, 14th May 2024New York, US & Online
Learn more about FT Community

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In